• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经皮肺动脉瓣植入术：现状与未来展望。

Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.

作者信息

Driesen Bart W, Warmerdam Evangeline G, Sieswerda Gert-Jan, Meijboom Folkert J, Molenschot Mirella M C, Doevendans Pieter A, Krings Gregor J, van Dijk Arie P J, Voskuil Michiel

机构信息

Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.

Department of Cardiology, Radboudumc, Nijmegen, Netherlands.

出版信息

Curr Cardiol Rev. 2019;15(4):262-273. doi: 10.2174/1573403X15666181224113855.

DOI:10.2174/1573403X15666181224113855
PMID:30582483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8142351/
Abstract

Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

摘要

大多数患有先天性心脏病（CHD）且右心室流出道（RVOT）功能障碍的患者一生中需要多次进行肺动脉瓣置换。自2000年经皮肺动脉瓣植入术（PPVI）问世以来，其数量不断增长，在全球范围内已超过10000例手术。总体而言，PPVI已被证明是安全有效的，但一些解剖变异可能会限制手术的成功率。本文综述了该手术的现状和未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/d0430c736007/CCR-15-262_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/de8176756f92/CCR-15-262_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/f5618e2f237d/CCR-15-262_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/74c9aaa96d4b/CCR-15-262_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/0a528be65424/CCR-15-262_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/301944d5fd43/CCR-15-262_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/7e2263c89521/CCR-15-262_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/d0430c736007/CCR-15-262_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/de8176756f92/CCR-15-262_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/f5618e2f237d/CCR-15-262_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/74c9aaa96d4b/CCR-15-262_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/0a528be65424/CCR-15-262_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/301944d5fd43/CCR-15-262_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/7e2263c89521/CCR-15-262_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b475/8142351/d0430c736007/CCR-15-262_F7.jpg

相似文献

1
Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.经皮肺动脉瓣植入术：现状与未来展望。
Curr Cardiol Rev. 2019;15(4):262-273. doi: 10.2174/1573403X15666181224113855.
2
Percutaneous Pulmonary Valve Implantation: Present Status and Evolving Future.经皮肺动脉瓣植入术：现状与未来发展。
J Am Coll Cardiol. 2015 Nov 17;66(20):2246-2255. doi: 10.1016/j.jacc.2015.09.055.
3
Percutaneous pulmonary valve implantation in grown-up congenital heart disease patients: Insights from the Zurich experience.成人先天性心脏病患者经皮肺动脉瓣植入术：来自苏黎世经验的见解。
J Interv Cardiol. 2018 Apr;31(2):251-260. doi: 10.1111/joic.12477. Epub 2017 Dec 25.
4
The standing of percutaneous pulmonary valve implantation compared to surgery in a non-preselected cohort with dysfunctional right ventricular outflow tract - Reasons for failure and contraindications.经皮肺动脉瓣植入术与非预选队列中右心室流出道功能障碍手术的比较 - 失败原因和禁忌症。
J Cardiol. 2019 Sep;74(3):217-222. doi: 10.1016/j.jjcc.2019.03.021. Epub 2019 Jun 21.
5
Transcatheter pulmonary valve implantation: will it replace surgical pulmonary valve replacement?经导管肺动脉瓣植入术：它会取代外科肺动脉瓣置换术吗？
Expert Rev Cardiovasc Ther. 2018 Mar;16(3):197-207. doi: 10.1080/14779072.2018.1435273. Epub 2018 Feb 12.
6
An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction.评估右心室流出道功能障碍患者行经皮肺动脉瓣植入术（PPVI）与外科肺动脉瓣置换术（PVR）的成本。
J Med Econ. 2011;14(1):47-52. doi: 10.3111/13696998.2010.545465. Epub 2011 Jan 11.
7
Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts.天然或修补后的右心室流出道经导管肺动脉瓣置换术的结果
Arch Cardiovasc Dis. 2014 Nov;107(11):592-8. doi: 10.1016/j.acvd.2014.07.045. Epub 2014 Sep 11.
8
Right ventricular remodelling after transcatheter pulmonary valve implantation.经导管肺动脉瓣植入术后右心室重塑
Catheter Cardiovasc Interv. 2017 Sep 1;90(3):407-417. doi: 10.1002/ccd.26966. Epub 2017 Mar 15.
9
Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.先天性心脏病修复术后右心室流出道功能障碍患者接受美敦力经导管肺动脉瓣植入术的结局：澳大利亚单中心首次报告经验
Heart Lung Circ. 2017 Oct;26(10):1085-1093. doi: 10.1016/j.hlc.2016.12.004. Epub 2017 Jan 24.
10
Percutaneous pulmonary valve implantation for reconstruction of a patch-repaired right ventricular outflow tract.经皮肺动脉瓣植入术用于修复补片修补的右心室流出道。
J Interv Cardiol. 2018 Feb;31(1):106-111. doi: 10.1111/joic.12443. Epub 2017 Sep 20.

引用本文的文献

1
Quantitative comparisons of pulmonary artery hemodynamics before and after Pulsta valve implantation in patients with Tetralogy of Fallot using computational fluid dynamics.运用计算流体动力学对法洛四联症患者肺动脉瓣植入Pulsta瓣膜前后的肺动脉血流动力学进行定量比较。
Front Cardiovasc Med. 2025 Jun 12;12:1586134. doi: 10.3389/fcvm.2025.1586134. eCollection 2025.
2
Percutaneous pulmonary valve implantation guided by three-dimensional rotational angiography.三维旋转血管造影引导下的经皮肺动脉瓣植入术
Int J Cardiol Congenit Heart Dis. 2024 Sep 12;18:100541. doi: 10.1016/j.ijcchd.2024.100541. eCollection 2024 Dec.
3

本文引用的文献

1
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会成人先天性心脏病管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Apr 2;139(14):e637-e697. doi: 10.1161/CIR.0000000000000602.
2
Endocarditis After Transcatheter Pulmonary Valve Replacement.经导管肺动脉瓣置换术后的心内膜炎。
J Am Coll Cardiol. 2018 Dec 4;72(22):2717-2728. doi: 10.1016/j.jacc.2018.09.039.
3
SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
Transcatheter valvular therapies in patients with left ventricular assist devices.
左心室辅助装置患者的经导管瓣膜治疗
Front Cardiovasc Med. 2023 Mar 13;10:1071805. doi: 10.3389/fcvm.2023.1071805. eCollection 2023.
4
First hybrid implantations of novel Salus-Valves in patients with severe pulmonary regurgitation: A case series.新型Salus瓣膜在重度肺动脉反流患者中的首例杂交植入术：病例系列报道
Front Cardiovasc Med. 2022 Nov 24;9:1059664. doi: 10.3389/fcvm.2022.1059664. eCollection 2022.
5
Advancing a Bulky Delivery System Using a Novel Technique During Percutaneous Pulmonary Valve Implantation.经皮肺动脉瓣植入术中应用新技术推进大体积输送系统。
Tex Heart Inst J. 2022 Sep 1;49(5). doi: 10.14503/THIJ-20-7541.
6
Percutaneous pulmonary valve implantation in India: Quo Vadis?印度的经皮肺动脉瓣植入术：何去何从？
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):310-314. doi: 10.4103/apc.apc_127_21. Epub 2021 Aug 26.
7
Preclinical study of a self-expanding pulmonary valve for the treatment of pulmonary valve disease.一种用于治疗肺动脉瓣疾病的自膨式肺动脉瓣的临床前研究。
Regen Biomater. 2020 Aug 22;7(6):609-618. doi: 10.1093/rb/rbaa035. eCollection 2020 Dec.
8
Cardiac Computed Tomography (CT) Evaluation of Valvular Heart Disease in Transcatheter Interventions.经导管介入治疗中心脏计算机断层扫描（CT）评估瓣膜性心脏病。
Curr Cardiol Rep. 2019 Nov 25;21(12):154. doi: 10.1007/s11886-019-1241-6.
SAPIEN 瓣膜经皮肺动脉瓣置换术无“预支架”：多中心经验。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):324-329. doi: 10.1002/ccd.27932. Epub 2018 Oct 23.
4
3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.Edwards SAPIEN 经导管心脏瓣膜在 COMPASSION 多中心临床试验中用于肺动脉位置的管道失效的 3 年结果。
JACC Cardiovasc Interv. 2018 Oct 8;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001.
5
Prediction of stenting related adverse events through patient-specific finite element modelling.通过患者特异性有限元建模预测支架置入相关不良事件。
J Biomech. 2018 Oct 5;79:135-146. doi: 10.1016/j.jbiomech.2018.08.006. Epub 2018 Aug 13.
6
The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation.经皮和手术生物肺动脉瓣植入术后细菌性心内膜炎的风险。
Int J Cardiol. 2018 Oct 1;268:55-60. doi: 10.1016/j.ijcard.2018.04.138.
7
Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet α-Gal-Free Porcine Pericardial Valve in the Native Right Ventricular Outflow Tract.新型自膨式经皮肺动脉瓣（Pulsta 瓣）植入术的可行性人体试验：使用编织型镍钛合金丝骨架和三叶型无α-Gal 猪心包瓣在自体右心室流出道。
Circ Cardiovasc Interv. 2018 Jun;11(6):e006494. doi: 10.1161/CIRCINTERVENTIONS.118.006494.
8
Percutaneous pulmonary valve implantation in patients with dysfunction of a "native" right ventricular outflow tract - Mid-term results.经皮肺动脉瓣植入术治疗“原生”右心室流出道功能障碍患者的中期结果。
Int J Cardiol. 2018 May 1;258:31-35. doi: 10.1016/j.ijcard.2017.11.091.
9
French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation.法国关于感染性心内膜炎和经皮肺动脉瓣植入术中心律转复和除颤器（Melody™）瓣膜的全国性调查。
Arch Cardiovasc Dis. 2018 Aug-Sep;111(8-9):497-506. doi: 10.1016/j.acvd.2017.10.007. Epub 2018 Mar 9.
10
First human implant of the Alterra Adaptive Prestent : A new self-expanding device designed to remodel the right ventricular outflow tract.首例人类植入Alterra自适应支架：一种旨在重塑右心室流出道的新型自膨胀装置。
Catheter Cardiovasc Interv. 2018 May 1;91(6):1125-1129. doi: 10.1002/ccd.27581. Epub 2018 Mar 9.